H-Leu-Ser-Lys-Leu-OH |
Catalog No.GA22646 |
The tetrapeptide LSKL prevents hepatic fibrosis in vivo via blocking TGFβ1 activation. LSAL (H-2144) has been used as inactive control.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 162559-45-7
Sample solution is provided at 25 µL, 10mM.
The tetrapeptide LSKL prevents hepatic fibrosis in vivo via blocking TGFβ1 activation. LSAL has been used as inactive control.
Review for H-Leu-Ser-Lys-Leu-OH
Average Rating: 5
(Based on Reviews and 21 reference(s) in Google Scholar.)Review for H-Leu-Ser-Lys-Leu-OH
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *